OOIR: Observatory of International Research

Papers

(The TQCC of Journal of the American College of Cardiology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Long-Duration Space Flight and Cardiac Morphology	1984
IMPACT OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS ON ATRIAL ARRHYTHMIAS IN ADVANCED HEART FAILURE: A POST-HOC ANALYSIS FROM FIGHT	1639
THE EFFECT OF AN ONLINE LEARNING MODULE ON TRAINEE UNDERSTANDING AND TROUBLESHOOTING OF MECHANICAL CIRCULATORY SUPPORT DEVICES IN THE CICU	1131
ATRIAL SHUNTING PROTECTS AGAINST LONGITUDINAL WORSENING OF RIGHT VENTRICULAR FREE WALL STRAIN IN HFPEF/HFMREF: FINDINGS FROM REDUCE-LAP HF	1011
FIRST CASE REPORT ON A RARE COMBINATION OF TWO UNUSUAL ANOMALIES: ABERRANT LEFT MAIN ARTERY ARISING FROM RIGHT CORONARY SINUS WITH CONGENITAL ABSENCE OF LEFT CIRCUMFLEX ARTERY	701
LONGITUDINAL CONTRACTILE DIASTASIS: A NOVEL MYOCARDIAL CONTRACTION-RELAXATION ABNORMALITY IN PATIENTS WITH AMYLOID CARDIOMYOPATHY	540
CATHTAB-LM: AN EFFICIENT LARGE LANGUAGE MODEL FOR AUTOMATED TRANSFORMATION OF UNSTRUCTURED CARDIAC CATHETERIZATION REPORTS INTO STRUCTURED DATASETS	529
CLINICAL OUTCOMES OF PULMONARY VEIN ISOLATION VERSUS ANTIARRHYTHMIC DRUGS AS FIRST-LINE THERAPY FOR ATRIAL FIBRILLATION: A PROPENSITY SCORE-MATCHED ANALYSIS	473
TEMPORAL AND GEOGRAPHICAL PATTERNS OF ISCHEMIC HEART DISEASE ATTRIBUTABLE TO PARTICULATE MATTER POLLUTION: A GLOBAL COMPREHENSIVE ANALYSIS FROM 1990 TO 2021	445
AGE AND COMORBIDITIES ASSOCIATED WITH HEALTHCARE UTILIZATION AFTER RECEIVING A SMARTWATCH IRREGULAR PULSE NOTIFICATION SUGGESTIVE OF ATRIAL FIBRILLATION: FINDINGS FROM THE APPLE HEART STUDY	444
VARICELLA ZOSTER VIRUS-RELATED MYOPERICARDITIS	432
IMPROVING ACCESS TO CARDIAC CARE IN RURAL AREAS - NARRATIVE INSIGHTS FROM PROJECT CARDIOGRAM, A DIGITAL HEALTH IMPLEMENTATION SCIENCE PROJECT	401
PULMONARY ENDARTERECTOMY: A LIFE CHANGING PROCEDURE FOR CTEPH	388
PATTERNS OF DIURETIC MANAGEMENT ON LENGTH OF STAY IN ACUTE HEART FAILURE WITH SERUM CREATININE INCREASES	374
PACING THROUGH THE COMPLICATIONS: FROM TEER TO TTVR TO PACEMAKER IN TRICUSPID VALVE REPAIR	344
STATEWIDE BURDEN AND TREND OF NON-RHEUMATIC CALCIFIC AORTIC VALVE DISEASE IN THE UNITED STATES FROM 1990-2021: AN INSIGHT FROM THE GLOBAL BURDEN OF DISEASE STUDY 2021	343
DISPARITIES IN MORTALITY AND RESOURCE UTILIZATION FOR ACUTE CORONARY SYNDROME WITH MECHANICAL SUPPORT DEVICES: A COMPARATIVE ANALYSIS OF WEEKEND VS. WEEKDAY ADMISSIONS USING NATIONAL INPATIENT DATA	328
COMPARISON OF ARTIFICIAL INTELLIGENCE MODELS FOR DETECTING LEFT VENTRICULAR SYSTOLIC DYSFUNCTION: A META-ANALYSIS OF CNN, DEEP LEARNING, AND DYNAMIC NEURAL NETWORKS	322
RIGHT VENTRICULAR CARDIAC RESYNCHRONIZATION IN A PATIENT WITH DEXTROCARDIA, CARDIOMYOPATHY, AND RIGHT BUNDLE BRANCH BLOCK	297
SAFETY EVENTS INVOLVING THE ANGIO-SEAL VIP DEVICE: A COMPREHENSIVE ANALYSIS FROM THE MAUDE DATABASE (2005-2024)	290
GOOD PERICARDIUM GIVEN A BAD WRAP: A RESTRICTIVE CARDIOMYOPATHY MASQUERADING AS CONSTRICTIVE PERICARDITIS	289
PHENOTYPES OF NON-ISCHEMIC REFRACTORY VENTRICULAR TACHYCARDIA/VENTRICULAR FIBRILLATION OUT-OF-HOSPITAL CARDIAC ARREST PATIENTS RECEIVING EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION	287
ASPIRIN DISCONTINUATION WITHIN 1 MONTH VS AT 3 MONTHS WITH TICAGRELOR MONOTHERAPY IN ACUTE CORONARY SYNDROME: AN INDIVIDUAL PATIENT DATA POOLED ANALYSIS OF TICO AND T-PASS TRIALS	273
ASSOCIATION OF FRAILTY AND HIGH SENSITIVITY C-REACTIVE PROTEIN WITH CARDIOVASCULAR DISEASE IN MIDDLE-AGED AND OLDER ADULTS: A NATIONWIDE PROSPECTIVE COHORT STUDY	256
SUCCESSFUL PERCUTANEOUS CLOSURE OF MITRAL VALVE PERIVALVULAR LEAK CAUSING SEVERE HEMOLYTIC ANEMIA WITH AMPLATZER DUCT OCCLUDER	231

CARDIAC MANIFESTATIONS OF MESOAMERICAN NEPHROPATHY	226
DYNAMIC LEFT VENTRICULAR OUTFLOW TRACT OBSTRUCTION IN AN ELDERLY WOMAN: A CASE OF RECURRENT SYNCOPE AND ACUTE DECOMPENSATION	223
OUTCOMES OF MECHANICAL THROMBECTOMY VERSUS SYSTEMIC THROMBOLYSIS AMONG PATIENTS WITH PULMONARY EMBOLISM: A NATIONWIDE STUDY	221
ONE BIRD WITH TWO STONES: LEFT ATRIAL APPENDAGE OCCLUSION USING TWO DIFFERENT DEVICES	216
GET WITH THE GUIDELINES FOR HEART FAILURE: A BRIEF EDUCATIONAL INTERVENTION FOR RESIDENTS	198
HEART’S WILD TANGO: A TALE OF ARVC	197
SCHOOL READINESS AMONG U.S. CHILDREN WITH AND WITHOUT CONGENITAL HEART CONDITIONS, NATIONAL SURVEY OF CHILDREN’S HEALTH 2022	192
PATIENT SHOCKED BY WEIGHT LOSS: A CASE OF INAPPROPRIATE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR FIRING	186
STATIN-INDUCED RHABDOMYOLYSIS IN A PATIENT WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: A CASE REPORT AND CLINICAL IMPLICATIONS	179
MANAGING CARDIAC RISKS IN PREGNANCY WITH LEFT VENTRICULAR NONCOMPACTION CARDIOMYOPATHY AND EBSTEIN’S ANOMALY	178
OUTCOMES OF PROTAMINE IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT: A SYSTEMATIC REVIEW AND META-ANALYSIS	174
RARE CASE OF HEPATIC ENCEPHALOPATHY TRIGGERED BY CARDIAC CIRRHOSIS	172
CONCURRENT PULMONARY FIBROSIS AND PULMONARY ARTERIAL HYPERTENSION APPROACHED BY CARDIOPULMONARY EXERCISE TESTING, AN ILLUSTRATIVE CASE REPORT	171
MEDICARE PRICE NEGOTIATION FOR 10 PRESCRIPTION DRUGS (2026): QUANTIFYING THE IMPACTS ON HEART FAILURE TREATMENT	171
CONCURRENT IMMUNE CHECKPOINT INHIBITOR INDUCED MYOCARDITIS & MYASTHENIA GRAVIS	166
INCIDENCE AND OUTCOMES OF PROSTHETIC VALVE ENDOCARDITIS IN ADULTS WITH CONGENITAL HEART DISEASE	164
WHEN HEART TRANSPLANTATION IS NOT AN OPTION IN COMPLEX CONGENITAL HEART DISEASES IN ADULTS: FONTAN SURGERY	163
A RARE CASE OF METASTATIC RENAL CELL CARCINOMA WITH DIRECT CARDIAC EXTENSION	162
EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND CARDIOVASCULAR DISEASES (EXACOS-CV): ONE IN THREE COPD PATIENTS EXPERIENCED CARDIOPULMONARY EVENTS DURING FOLLOW-UP	162
BEWARE OF FLECAINIDE TOXICITY: A CASE REPORT	158
LOST THE GRASP — A CASE OF MITRACLIP SINGLE-LEAFLET DETACHMENT	157
A CASE OF AN ANOMALOUS RIGHT CORONARY ARTERY ARISING FROM A SINGLE CORONARY ARTERY ORIGIN	156
FROM CYSTITIS TO CARDIAC ARREST: A FULMINANT MYOCARDITIS SCENARIO CAUSED BY ADENOVIRUS	155
EFFECT OF TIME TO EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION ON SURVIVAL OUTCOMES IN OUT OF HOSPITAL AND IN HOSPITAL CARDIAC ARREST PATIENTS	155
CORONARY-CAMERAL FISTULA DISCOVERED IN A PATIENT PRESENTING AS NSTEMI AND ACUTE HEART FAILURE: A CLINICAL RARITY	154
IMPACT OF DIFFERENT OBESITY PHENOTYPES ON IN-HOSPITAL MORTALITY IN ELDERLY CARDIAC ARREST RELATED HOSPITALIZATIONS; A POPULATION BASED MULTI CENTER PERSPECTIVE	153
ASYMPTOMATIC HYPOXEMIA: FROM URGENT CARE TO ECMO	153
IMPACT OF MUSCULOSKELETAL FEATURES ON NON-SYNDROMIC ANEURYSMS: AN ANALYSIS OF THE SEVERITY OF VASCULAR OUTCOMES	151
RIVAROXABAN AND WALKING ABILITY IN PATIENTS WITH SYMPTOMATIC PERIPHERAL ARTERY DISEASE AFTER LOWER EXTREMITY REVASCULARIZATION: INSIGHTS FROM VOYAGER PAD	151
INFECTIVE ENDOCARDITIS AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT UNDERGOING SURGICAL MANAGEMENT: INSIGHTS FROM A TERTIARY CARE CENTER OF EXCELLENCE	151
PERSISTENT LEFT SUPERIOR VENA CAVA ISOLATION WITH PULSED-FIELD ABLATION	150
IMPLANTABLE LOOP RECORDER MALFUNCTION FOLLOWING CARDIOVERSION: MISSED SIGNAL LOSS AND DEVICE FAILURE IN THE ABSENCE OF REMOTE MONITORING ALERTS	148
CARDIOVASCULAR OUTCOMES OF EMPAGLIFLOZIN IN PATIENTS WITH AND WITHOUT TYPE 2 DIABETES MELLITUS; A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS	148
NAVIGATING CARDIOTOXICITY IN BREAST CANCER THERAPY: EVALUATING THE PREDICTIVE STRENGTH OF THE HFA-ICOS RISK STRATIFICATION TOOL	147
INTERNATIONAL EXPERIENCE OF EFFICACY AND OUTCOMES OF HIGH RISK PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY WITH IMPLANTED CARDIOVERTER DEFIBRILLATORS	147
ARRHYTHMOGENIC RISK IN V142I TRANSTHYRETIN AMYLOID CARDIOMYOPATHY	145
HIDDEN IN PLAIN SIGHT; HISTOPLASMA ENDOCARDITIS IN A PATIENT WITH DISSEMINATED INFECTION AND AIDS	144
LEFT ATRIAL MASS IN A PATIENT WITH WEGENER’S GRANULOMATOSIS: A RARE CASE OF PYREXIA OF UNKNOWN ORIGIN MIMICKING INFECTIVE ENDOCARDITIS	142
CLINICAL CHARACTERISTICS AND LONGITUDINAL OUTCOMES OF A SOUTHEAST ASIAN TRANSCATHETER AORTIC VALVULAR IMPLANTATION REGISTRY	141
PREDICTORS AND TEMPORAL TRENDS OF HIGH-POTENCY P2Y12 INHIBITOR USE AFTER PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROME (ACS): IMPACT OF ISAR-REACT 5 AND 2021 ACC/AHA REVASCULARIZATION	141
MYOCARDIAL FIBROSIS AND VENTRICULAR ARRHYTHMIA AFTER LVAD IMPLANTATION	139
MECHANICAL CIRCULATORY SUPPORT IN FEMALES WITH SPONTANEOUS CORONARY ARTERY DISSECTION AND CARDIOGENIC SHOCK: TRENDS, PREDICTORS, AND SURVIVAL INSIGHTS	138
FIRST IMPELLA RP FLEX PLACED DURING OPEN HEART SURGERY IN THE USA	137
DIFFUSION TENSOR CARDIAC MAGNETIC RESONANCE FOR CONTRAST-FREE DETECTION OF EARLY CARDIAC AMYLOIDOSIS IN CARPAL TUNNEL SYNDROME	132
CONSTRICTIVE PERICARDITIS AS A RARE MANIFESTATION OF ISOLATED CARDIAC TUBERCULOSIS	130
INTRACARDIAC ECHOCARDIOGRAPHY VERSUS TRANSESOPHAGEAL ECHOCARDIOGRAPHY GUIDANCE ON LEFT ATRIAL APPENDAGE OCCLUSION IN PATIENTS WITH ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS	129
HYPERTENSIVE RESPONSE DURING DOBUTAMINE STRESS ECHOCARDIOGRAPHY AND RISK OF NEW ONSET HEART FAILURE	129
IS CARDIONEUROABLATION A SAFE THERAPEUTIC APPROACH FOR NEUROCARDIOGENIC SYNCOPE?	128
SUCCESSFUL RIGHT SUBCLAVIAN IMPELLA PLACEMENT IN A PATIENT WITH COARCTATION OF THE AORTA AND SMALL FEMORAL ARTERIES: A NOVEL APPROACH FOR MECHANICAL CIRCULATORY SUPPORT	126
DOUBLE JEOPARDY: LEFT VENTRICULAR ANEURYSM AND VENTRICULAR SEPTAL DEFECT POSTMYOCARDIAL INFARCTION	126

A MISTERY OF THE RIGHT ATRIUM: UNUSUAL FINDINGS IN A COMPLEX CARDIAC CASE	126
“WHAT THE MOJO!”A CASE REPORT OF SYNTHETIC CANNABINOID (MOJO) INDUCED ST SEGMENT ELEVATED MYOCARDIAL INFARCTION	123
ASSESSING THE IMPACT OF HOSPITAL VOLUME THRESHOLDS ON IN-HOSPITAL MORTALITY AMONG HEART TRANSPLANT PATIENTS: AN ANALYSIS OF THE NATIONAL INPATIENT SAMPLE (2017-2021)	122
EXPLORING STATIN UNDERUTILIZATION IN PATIENTS WITH LDL ≥ 190	121
ARTERIAL STIFFNESS PARAMETERS IN OLDER ADULTS WITH AND WITHOUT STANDING HYPERTENSION	120
COMPARATIVE OUTCOMES OF INTRACARDIAC VERSUS TRANSESOPHAGEAL ECHOCARDIOGRAPHY FOR LEFT ATRIAL APPENDAGE OCCLUSION: A SYSTEMATIC REVIEW AND META-ANALYSIS	117
RISKS FOR SUDDEN CARDIAC (SCD) AND UNDETERMINED CAUSE OF DEATH (UDD) AMONG PEOPLE WITH HIV (PWH) IN THE REPRIEVE PRIMARY CARDIOVASCULAR PREVENTION TRIAL	112
CORONARY PLAQUE PATTERNS AMONG SYMPTOMATIC AND ASYMPTOMATIC PATIENTS: AN ADVANCE SUBSTUDY	111
SAFETY AND EFFICACY OF PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE IMPLANTATION	111
TEMPORAL CHANGES IN PREVALENCE AND SEVERITY OF PULMONARY HYPERTENSION AND RELATIONSHIP TO OUTCOMES IN COARCTATION OF AORTA	111
LONG-TERM OUTCOMES IN YOUNG PATIENTS WITH SPONTANEOUS CORONARY ARTERY DISSECTION: A SYSTEMATIC REVIEW AND POOLED ANALYSIS	111
LOW QRS VOLTAGES AND QRS FRAGMENTATION IN ADOLESCENCE - FINDINGS FROM THE BEATIT SCREENING PROGRAM	106
CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME RISK FACTOR PREVALENCE, TREATMENT, AND CONTROL AMONG SOUTH ASIAN AND CHINESE AMERICANS	106
RIGHT VENTRICULAR OUTFLOW TRACT VELOCITY TIME INTERVAL: AN INVALUABLE YET FORGOTTEN ECHOCARDIOGRAPHIC VARIABLE	105
RIGHT POSTERIOR DESCENDING ARTERY MYOCARDIAL BRIDGE MANIFESTING AS ST-ELEVATION MYOCARDIAL INFARCTION	105
INTENSIVE VS. STANDARD BLOOD PRESSURE MANAGEMENT IN HIGH-RISK CARDIOVASCULAR PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF MORTALITY AND ADVERSE EVENTS	104
EVENTS OF MYOCARDIAL INFARCTION AMONG ADULTS WITH COCAINE OVERDOSE AND PREDICTORS OF MORTALITY; A RETROSPECTIVE STUDY INVOLVING 105695 CASES	101
MAPPING ACTIVATION IN THE INVERSE AREA (MAIA): A NOVEL TECHNIQUE TO RAPIDLY IDENTIFY GAPS IN PRIOR ABLATION LINES	99
TREATMENT OF SEVERE RIGHT-SIDED INFECTIVE ENDOCARDITIS WITH MECHANICAL ASPIRATION VERSUS VALVE SURGERY: COMPARISON OF OUTCOMES AND INSIGHTS FROM A UNITED STATES REAL-WORLD DATABASE	99
A RARE CAUSE OF CONSTRICTIVE PERICARDITIS: PRIMARY PERICARDIAL MESOTHELIOMA	98
IMPACT OF TRICUSPID VALVE REPLACEMENT ON OUTCOMES IN TRANSPOSITION OF THE GREAT ARTERIES AND SYSTEMIC RIGHT VENTRICLE	98
CONTRAST-INDUCED ENCEPHALOPATHY AFTER PERCUTANEOUS CORONARY INTERVENTION WITH IOHEXOL	97
HIDDEN IN PLAIN SIGHT: A DECADE-LONG UNDETECTED PACEMAKER LEAD MISPLACEMENT	97
MASSIVE LEFT VENTRICULAR PSEUDOANEURYSM IN A PATIENT WITH PERSISTENT SYMPTOMS FOLLOWING SUSPECTED PNEUMONIA: A CASE REPORT	97
DETERMINING EXTENT OF NO REFLOW SOON AFTER REPERFUSION WITH MYOCARDIAL CONTRAST ECHOCARDIOGRAPHY USING INTRAVENOUS MICROBUBBLE ADMINISTRATION	96
UNCOVERING CRITICAL TRENDS: TRENDS IN 30-DAY READMISSION, MORTALITY, AND RESOURCE UTILIZATION AMONG FEMALE PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION AND BREAST CANCER	95
HEARTNAVIGATOR GUIDED TRANSCATHETER AORTIC VALVE REPLACEMENT IN A RADIOLUCENT BIOPROSTHETIC AORTIC VALVE	94
CULTURE-NEGATIVE ENDOCARDITIS COMPLICATED BY CARDIAC VALVULAR ANEURYSMS	94
CHANGING MORTALITY TRENDS IN CARDIOVASCULAR DISEASES: A COMPARATIVE ANALYSIS BEFORE, DURING, AND AFTER THE PANDEMIC	93
LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION COMBINED WITH CRYOBALLOON ABLATION FOR VENTRICULAR TACHYCARDIA	93
MECHANICAL TRICUSPID VALVE THROMBOSIS SUCCESSFULLY TREATED WITH ANTICOAGULATION	92
THE RISK AND REVERSIBILITY OF OSIMERTINIB-RELATED CARDIOTOXICITY IN A REAL-WORLD POPULATION	92
MYOCARDIAL METABOLIC RESPONSE TO CABG SURGERY AS ASSESSED BY HYPERPOLARIZED CARBON-13 MRI	92
IMPLICATIONS OF EXERCISE WEDGE PRESSURE IN HFPEF IDENTIFIED BY PRESSURE-FLOW SLOPE	91
INCREMENTAL PROGNOSTIC VALUE OF CARDIAC MAGNETIC RESONANCE BEYOND THE TRADITIONAL BIOMARKER STAGING SYSTEM IN TRANSTHYRETIN CARDIAC AMYLOIDOSIS	91
A RARE CASE OF SUCCESSFUL HEART TRANSPLANT IN A PATIENT WITH SPORADIC INCLUSION BODY MYOSITIS	91
CORONARY ARTERY FISTULAE ARE ASSOCIATED WITH THE APICAL VARIANT OF HYPERTROPHIC CARDIOMYOPATHY	90
IMPACT OF SMOKING ON BURDEN AND TRENDS OF AORTIC ANEURYSM ACROSS 204 COUNTRIES AND TERRITORIES: COMPARATIVE GLOBAL ANALYSIS FROM THE GLOBAL BURDEN OF DISEASE 2021	89
SEVERE AORTIC REGURGITATION IS ASSOCIATED WITH ELEVATED WALL SHEAR STRESS	89
COMPARISON OF HOSPITAL OUTCOMES OF TRANSCATHETER MITRAL VALVE REPAIR WITH MITRACLIP BETWEEN PATIENTS <65 YEARS OLD VS PATIENTS <65 YEARS OLD	89
PHENOTYPIC IMAGING PATTERNS ON MYOCARDIAL METABOLIC PET CAN CHARACTERIZE CARDIOVASCULAR OUTCOMES IN BIOPSY-PROVEN SARCOIDOSIS PATIENTS	88
COMPRESSING THE RIGHT VENTRICLE: AN UNUSUAL ETIOLOGY OF SHOCK	88
MACHINE LEARNING IDENTIFIES ABLATION AND VOLTAGE PARAMETERS TO PREDICT FIRST PASS ISOLATION AND ATRIAL FIBRILLATION RECURRENCE	88
FROM INFUSION TO DYSFUNCTION: REVEALING TAKOTSUBO CARDIOMYOPATHY AFTER POLATUZUMAB CHEMOTHERAPY	87
HIGHER REHOSPITALIZATION IN LEAN HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION: A RETROSPECTIVE COHORT STUDY	87
BATTLING CRITICAL DECISIONS: AMLODIPINE TOXICITY, HIGH-OUTPUT HEART FAILURE, VASOPLEGIA, AND ECMO SUPPORT	87
A SHOCKING CASE OF TUMOR IN TRANSIT	86
IMMUNE CHECKPOINT INHIBITOR MYOCARDITITS: A CHALLENGING CARDIOVASCULAR COMPLICATION	86
LAD BRIDGE IS FALLING DOWN: A CASE OF SYMPTOMATIC MYOCARDIAL BRIDGING IN AN ACTIVE DUTY PATIENT	86
PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE (PCORI)’S PORTFOLIO OF COMPARATIVE EFFECTIVENESS RESEARCH (CER) STUDIES ON IMPROVING CARDIOVASCULAR HEALTH	85
DETECTION OF WATCHMAN DEVICE PERFORATION 45 DAYS POST-IMPLANTATION: A UNIQUE CASE REPORT	85
THE 1-YEAR EFFECTIVENESS OF A REMOTE TEAM-BASED GUIDELINE DIRECTED MEDICATION TITRATION PROGRAM IN TYPE 2 DIABETES AT HIGH CARDIOVASCULAR AND KIDNEY RISK COMPARED WITH STANDARD OF CARE	85
IMPACT OF TRUE BIFURCATION LESIONS ON PROCEDURAL TECHNIQUES AND OUTCOMES OF BIFURCATION PERCUTANEOUS CORONARY INTERVENTION	85
CARDIAC ARRHYTHMIA REGISTRY OF ATHLETES - THE EFFECTS OF CATHETER ABLATION ON QUALITY OF LIFE	84
TRENDS OF INTRAVASCULAR IMAGING USE IN BIFURCATION PERCUTANEOUS CORONARY INTERVENTIONS: INSIGHTS FROM THE PROGRESS-BIFURCATION REGISTRY	84
TACHY AND BRADY-ARRHYTHMIA MANAGEMENT IN COMPLEX CONGENITAL HEART DISEASE	84
RACIAL AND GENDER DISPARITIES IN CLINICAL OUTCOMES OF ACUTE ST-SEGMENT-ELEVATION MYOCARDIAL INFARCTION RELATED MECHANICAL COMPLICATIONS: INSIGHTS FROM THE NATIONAL INPATIENT SAMPLE DATABASE	83
ISOLATED CARDIAC SARCOIDOSIS PRESENTING AS REFRACTORY ATRIAL ARRHYTHMIAS IN A YOUNG HEALTHY FEMALE	83
AN UNUSUAL CASE OF NON-TRAUMATIC CHYLOTHORAX POST-CARDIAC TRANSPLANTATION	82
Shining a New Light Into the Black Box	81
Cardiac Arrest and Sudden Death	80
Contents	79
Audio Summary	79
GENDER DIFFERENCES IN REFERRAL PATTERNS FOR EVALUATION OF STABLE CORONARY ARTERY DISEASE (CAD) BY CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY (CCTA)	79
The Pathogenetic Link Between Ozone Pollution and Cardiovascular Disease	79
THE IMPACT OF HYPERTENSION ON MATERNAL OUTCOME IN WOMEN WITH COARCTATION OF THE AORTA	78
CAN THE PRESENCE OF BREAST ARTERIAL CALCIFICATION ON MAMMOGRAPHY INDICATE INCREASED RISK OF CORONARY ARTERY DISEASE? A SYSTEMIC REVIEW AND META-ANALYSIS	78
CORONARY BIFURCATION SIDE BRANCH LESIONS: DRUG-COATED BALLOONS VS. NON-COATED BALLOON ANGIOPLASTY	78
APPLICATION OF ACC/AHA 2020 HEART FAILURE CLINICAL PERFORMANCE AND QUALITY MEASURES FOR ADULTS WITH HEART FAILURE IN A MIDDLE-INCOME-NATION	77
TAKAYASU'S ARTERITIS AS NON-TRADITIONAL RISK FACTOR FOR THE CARDIOVASCULAR DISORDERS - A POPULATION BASED STUDY	77
DEVELOPMENT AND VALIDATION OF AN OUTCOME PREDICTION MODEL FOR REPAIRED TETRALOGY OF FALLOT: THE INDICATOR COHORT	77
FULL COVER STENTING MAY WORSEN CLINICAL OUTCOME FOR THE TREATMENT OF FEMOROPOPLITEAL LESIONS INVOLVING DISTAL POPLITEAL ARTERY	76
AFRICAN AMERICAN WITH ATRIAL FIBRILLATION (AF) AND HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF) ARE AT HIGHER RISK OF MORTALITY	76
PERCUTANEOUS CORONARY INTERVENTION OUTCOMES IN PATIENTS WITH LIVER CIRRHOSIS A META ANALYSIS	76
THE IMPACT OF RACIAL DISPARITIES ON DIAGNOSIS AND TREATMENT OF PERIPHERAL ARTERY DISEASE	76
ADULTS WITH DOWN SYNDROME: UPDATE ON SAFETY AND LONG-TERM OUTCOMES OF CARDIAC SURGERY AND PERCUTANEOUS INTERVENTIONS	76
A CASE OF WIDE COMPLEX TACHYCARDIA IN A PATIENT WITH PROPIONIC ACIDEMIA AND LONG QT SYNDROME	75
CAUSE OF DEATH ANALYSIS IN PATIENTS WITH INTERMEDIATE RISK ACUTE PULMONARY EMBOLISM	75
LONG TERM EFFECTS OF SARS-COV-2 INFECTION ON CHILDREN'S VASCULATURE	75
DOUBLE TROUBLE: NEW ONSET DYNAMIC LVOT OBSTRUCTION AFTER TAVR	75

CAUSE AND CIRCUMSTANCE OF VERY LATE STENT THROMBOSIS ASSESSED BY OPTICAL COHERENCE TOMOGRAPHY IN JAPANESE PATIENTS	75
REPRESENTATION OF WOMEN AMONG CARDIOLOGY GRAND ROUNDS SPEAKERS AT ACADEMIC CENTERS IN THE UNITED STATES	74
COMPARISON OF THREE-YEAR OUTCOMES OF DRUG-COATED BALLOON ANGIOPLASTY IN TOTALLY OCCLUSIVE VS. NON-OCCLUSIVE IN-STENT RESTENOSIS OF DRUG-ELUTING STENTS	73
THE IMPORTANCE OF EARLY RECOGNITION OF DELIRIUM IN PATIENTS UNDERGOING TRANSCATHETER AORTIC AND MITRAL VALVE REPLACEMENT	73
PROPER USE OF CHRONIC TOTAL OCCLUSIONS (CTO) HYBRID ALGORITHM TO SECURE LEFT MAIN DISSECTION	71
CONGENITAL HEART DEFECTS AND THE SEVERITY OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER, A META-ANALYSIS.	71
ECHOCARDIOGRAPHIC EPICARDIAL FAT THICKNESS AS A PREDICTOR FOR RECURRENCE OF PREGNANCY-INDUCED HYPERTENSION IN EGYPTIANS	70
“PAUSE AND EFFECT”: AN ADVERSE REACTION OF TICAGRELOR.	70
REAL-WORLD PERFORMANCE AND VALIDATION OF THE ARTIFICIAL INTELLIGENCE ENHANCED ELECTROCARDIOGRAM FOR THE DETECTION OF AMYLOIDOSIS	70
EMBOLIZATION OF MECHANICAL AORTIC VALVE	69
LONG-TERM OUTCOMES OF HEART TRANSPLANTATION AND LEFT VENTRICULAR ASSIST DEVICES IN PATIENTS LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS: A SYSTEMATIC REVIEW AND META-ANALYSIS	69
IS SYSTOLIC AND DIASTOLIC FUNCTION INCLUDING GLOBAL LONGITUDINAL STRAIN BY ECHOCARDIOGRAPHY COMPROMISED IN ADULT PATIENTS TREATED WITH CD19 CAR T-CELL THERAPIES FOR HEMATOLOGICAL MALIGNANCIES IN THOSE	69
IMPACT OF RACE ON CLINICAL OUTCOMES IN PATIENTS WITH SECONDARY MITRAL REGURGITATION: ANALYSIS FROM THE COAPT TRIAL	69
GENDERED SOCIAL DETERMINANTS OF HEALTH AND RISK OF MAJOR ADVERSE OUTCOMES IN ATRIAL FIBRILLATION	69
IMPACT OF GEOGRAPHICAL VARIATION BETWEEN EUROPE AND ASIA ON CLINICAL OUTCOMES IN PATIENTS WITH HIGH BLEEDING RISK (HBR) AND BIODEGRADABLE-POLYMER SIROLIMUSELUTING CORONARY STENT: A SUBSTUDY OF MASTER	69
AN EXPLORATORY STUDY OF EFFECTIVENESS AND SAFETY OF RIVAROXABAN IN PATIENTS WITH LEFT VENTRICULAR THROMBUS (R-DISSOLVE)	69
MYOCARDIAL FDG UPTAKE VARIATION AND ITS RELATIONSHIP WITH SURVIVAL DURING IMMUNOTHERAPY	69
IMPACT OF THE $35 INSULIN PROGRAM ON OUT-OF-POCKET COSTS UNDER MEDICARE PART D	68
PATIENT REPORTED OUTCOMES OF CATHETER ABLATION FOR ATRIAL FIBRILLATION IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION	67
SHINGLE-VACCINE ASSOCIATED MYOCARDITIS-A CASE REPORT	67
SEX DIFFERENCES IN OUTCOMES AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT WITH NEWER GENERATION DEVICES: A META-ANALYSIS	67
HEALTH STATUS PRESENTATION THRESHOLDS IN REAL-WORLD PERIPHERAL ARTERY DISEASE SPECIALTY CARE	66
SKIN DEEP BEFORE CHANGE OF HEART-MELANOMA CHECK POINT INHIBITOR INDUCED MYOCARDITIS	66
A NOVEL METHOD FOR IDENTIFYING DIFFUSE MYOCARDIAL ISCHEMIA DURING MENTAL STRESS PREDICTS RECURRENT HEART FAILURE IN INDIVIDUALS WITH RECENT MYOCARDIAL INFARCTION	64
DEMOGRAPHIC AND CLINICAL DETERMINANTS OF ISCHEMIC WORKUP IN PATIENTS WITH HEART FAILURE	64
IMPACT OF CYTOCHROME 5 REDUCTASE 3 PARTIAL LOSS OF FUNCTION ON MAJOR ADVERSE CARDIOVASCULAR EVENTS IN BLACK ADULTS	64
RIGHT MASS, WRONG TIME: METASTATIC ECCRINE POROCARCINOMA TO THE RIGHT VENTRICLE	64
EVERY ECHODENSE MASS IS NOT TISSUE- A CASE OF AN INTRA-CORONARY STENT PROTRUDING INTO THE AORTIC LUMEN	64
NATIONAL TRENDS OF MECHANICAL SUPPORT UTILIZATION DURING PERCUTANEOUS CORONARY INTERVENTIONS IN CHRONIC TOTAL OCCLUSION	64
THE EFFECTIVENESS AND FEASIBILITY OF USING MULTI-LEAD ECG MONITORING COMBINED WITH A PROGRAMMED INTRACAVITARY ECG TO COMPLETE LEFT BUNDLE BRANCH AREA PACING	64
A Genetic Dissection of Vascular Risk Factors for Cervical Artery Dissection	64
CARDIOVASCULAR EVENTS IN PATIENTS WITH VTE: A COHORT STUDY IN REGION STOCKHOLM	63
SGLT2 INHIBITOR USE IN HFPEF ASSOCIATED WITH SEVERE SEPSIS AND SEPTIC SHOCK AND A NEW ONSET CARDIOMYOPATHY	63
IS EXPOSURE TO EPSTEIN-BARR VIRUS A RISK FACTOR FOR LONG-COVID?	62
TCT-575 Post Market Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold: 24-Month Clinical Outcomes in First 100 Patients	62
TCTAP C-189 A Challenging Case Report: Transcatheter Occulsion One Coronary Artery Fistula From Right Coronary Artery to Left Ventricule	62
LVOT OBSTRUCTION AFTER SURGICAL AORTIC VALVE REPLACEMENT TREATED WITH ALCOHOL SEPTAL ABLATION	62
TCTAP C-183 Device-Related Hemolytic Anemia After Transcatheter Closure of a Ruptured Ventricular Septum: To Wait or to Act?	61
A COMBINED APPROACH USING HIGH-SENSITIVE TROPONIN I AND N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE FOR RISK STRATIFICATION IN PATIENTS WITH CORONAVIRUS DISEASE 2019	61
Need for ‘One-Stop-Shop’ Heart-Brain-Placental Imaging in Fetal Congenital Heart Disease	61
TCTAP C-059 A Hard Decision and the Only Option : Provisional LM Stenting in Very Calcified Vessel	61
TCT-247 Hemodynamic Comparison of Resilia and Sapien 3/Ultra Transcatheter Heart Valves in Transcatheter Aortic Valve Replacement	61
PERFORATIONS IN THE CATHLAB & HOW TO BAIL OUT	60
CARDIOVASCULAR OUTCOMES IN PATIENTS WITH UNDERLYING PRIMARY IMMUNODEFICIENCY AND SEPTIC SHOCK	60
TCTAP C-042 LAD – Diagonal Bifurcation PCI by Mini Crush Technique	60
THE GREAT MIMICKER: IMMUNE CHECKPOINT INHIBITOR INDUCED MYOCARDITIS	59
A COMPLEX CASE OF FISTULOUS TRACT BETWEEN LEFT ANTERIOR DESCENDING ARTERY AND PULMONARY ARTERY	59
2D ECHOCARDIOGRAPHY IS SENSITIVE BUT NOT SPECIFIC FOR LEFT VENTRICULAR HYPERTROPHY IN HFPEF: COMPARISON WITH 3D ECHOCARDIOGRAPHY	59
OH NO! NOT ANOTHER POCKET INFECTION: A DEVICE IMPLANTATION CHALLENGE	59
PERIPARTUM CARDIOMYOPATHY IN THE SETTING OF A COMPLICATED PREGNANCY AND COVID-19 INFECTION	59
EXTREMELY LARGE AORTIC ANNULUS TAVR USING OVER-EXPANDED EDWARDS SAPIEN 3 VALVE WITH RENAL FUNCTION AND FUNCTIONAL CLASS IMPROVEMENT AFTER THE PROCEDURE.	59
A RARE CASE OF VERAPAMIL RESISTANT IDIOPATHIC LEFT FASCICULAR VENTRICULAR TACHYCARDIA	58
TCTAP C-065 A Wellen’s Syndrome: Crucial Patterns to Recognize	58
Defibrillator or No Defibrillator With CRT	58
Association Between High-Sensitivity Cardiac Troponin, Myocardial Ischemia, and Revascularization in Stable Coronary Artery Disease	58
Reply	58
CLINICAL CHARACTERISTICS, EVALUATION AND OUTCOMES OF CHYLOPERICARDIUM: A SYSTEMATIC REVIEW	57
TCT-189 The Efficacy and Safety of an Adjunctive Transcoronary Pacing Strategy During Rotational Atherectomy: The Results of the Strategy to Rotablate and PACE (ROTA-PACE) Study	57
GEOGRAPHIC DISTRIBUTION AND CLINICAL OUTCOMES AMONG PATIENTS WITH TRANSCATHETER MITRAL VALVE REPAIR IN THE UNITED STATES	57
PULMONARY HYPERTENSION AND RIGHT VENTRICULAR FAILURE IN THE SETTING OF UNILATERAL ABSENCE OF THE RIGHT PULMONARY ARTERY, CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION AND RIGHT LUNG PERFUSION VIA THE	57
EFFUSIVE CONSTRICTIVE PERICARDITIS RELATED TO COVID 19	57
ANALYZING THE PEDIATRIC CARDIOLOGISTS RESPONSE TO CARDIOMYOPATHY IN BARTH SYNDROME: AN ONLINE SURVEY REPORT	57
A RARE CASE OF CONSTRICTIVE PERICARDITIS FOLLOWING COVID-19 EXPOSURE AND VACCINATION	57
WHOM TO BELIEVE? POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY AND NEAR-INFRARED SPECTROSCOPY INTRAVASCULAR ULTRASOUND IMAGING IN VULNERABLE CORONARY PLAQUE DETECTION	57
ASSOCIATION OF TRANSTHYRETIN VAL122ILE VARIANT WITH INCIDENT HEART FAILURE AND MORTALITY AMONG BLACK AMERICANS	56
FROM SEPSIS TO STEMI: A CASE OF SHIFTING LEFT VENTRICULAR OBSTRUCTION	56
EOSINOPHILIC MYOCARDITIS AND LOEFFLER ENDOCARDITIS IN THE SETTING OF HYPEREOSINOPHILIC SYNDROME: DEMOGRAPHICS, CARDIAC IMAGING, MANAGEMENT AND OUTCOMES	56
DIAGNOSING CONGENITAL HEART DISEASE AT 63 YEARS OLD	56
CLINICAL AND ECONOMIC OUTCOMES OF PHARMACOLOGICAL STRESS TESTS IN PATIENTS WITH A HISTORY OF COVID-19	56
PAPILLARY MUSCLE ABNORMALITY AS AN ELECTROCARDIOGRAPHIC MIMICKER OF APICAL HYPERTROPHIC CARDIOMYOPATHY	56
GENDER DISPARITY IN OUTCOMES OF PATIENTS UNDERGOING LEFT ATRIAL APPENDAGE OCCLUSION: A SYSTEMATIC REVIEW AND META-ANALYSIS	55
UNEXPLAINED LEFT VENTRICULAR DYSFUNCTION: HOW IS CORONARY ANGIOGRAPHY USEFUL TODAY?	55
EXTRACELLULAR MATRIX REMODELING IN ANTHRACYCLINE-INDUCED HEART FAILURE	55
PRIMARY TRICUSPID REGURGITATION AND PATENT FORAMEN OVALE: A RARE CAUSE OF HYPOXEMIA	54
EFFICACY OF TRANSCATHETER INTERATRIAL SHUNT DEVICES IN HEART FAILURE: A SYSTEMATIC REVIEW AND META-ANALYSIS	54
CARDIOVASCULAR DISEASE DIAGNOSIS USING CARDIOVASCULAR IMAGING AND ARTIFICIAL INTELLIGENCE	54
CARDIAC MASS IN A PATIENT WITH RELAPSING CHRONIC LYMPHOCYTIC LEUKEMIA WITH NONDIFFUSE BONE MARROW INVOLVEMENT	54
HEMODYNAMICS IN CONSTRICTIVE PERICARDITIS	54
SPONTANEOUS CORONARY ARTERY DISSECTION. DEMOGRAPHIC AND ANGIOGRAPHIC CHARACTERISTICS FINDINGS IN THE SCALIBUR BRAZILIAN REGISTRY	54
A RARE CASE OF EMBRYONIC DEXTROCARDIA: MULTIMODALITY IMAGING TO ASSIST IN PACEMAKER PLACEMENT FOR HIGH GRADE ATRIOVENTRICULAR BLOCK	54
ECHOCARDIOGRAPHY-BASED CONVOLUTIONAL NEURAL NETWORK ACCURATELY DIFFERENTIATES ETIOLOGIES OF INCREASED LEFT VENTRICULAR WALL THICKNESS	54
IMPACT OF MALNUTRITION BY GERIATRIC NUTRITIONAL RISK INDEX IN ELDER PATIENTS WITH LEFT VENTRICULAR ASSIST DEVICE: AN INTERMACS ANALYSIS	53
EFFECTS OF SALT SUBSTITUTES ON BLOOD PRESSURE AND CLINICAL OUTCOMES IN DIFFERENT POPULATION GROUPS: A SYSTEMATIC REVIEW AND META-ANALYSIS	53
MATERNAL CARDIAC EVENTS AMONG PREGNANT WOMEN WITH M-WHO CLASS III AND IV AT THE FIRST CARDIO-OBSTETRIC CLINIC IN IRAQ	53
PERSISTENT BLOODY DIARRHEA IN A HEART TRANSPLANT PATIENT	52
METHYLMALONIC ACIDEMIA: A RARE CAUSE OF REVERSIBLE DILATED SYSTOLIC HEART FAILURE	52
HEART FAILURE IS ASSOCIATED WITH INCREASED ALL-CAUSE MORTALITY IN TRANSVENOUS LEAD EXTRACTION: A SYSTEMATIC REVIEW AND META-ANALYSIS	52
A BABY SO ADORABLE MY HEART CANTU HELP BUT STOP: A CASE OF PERIPARTUM COMPLETE HEART BLOCK WITH GENETIC PREDISPOSITION	52
TCT-127 Medical Therapy Versus Early Revascularization in Diabetics With Chronic Total Occlusion of Coronary Arteries: A Meta-analysis and Systematic Review	52
A MIMICKER OF CONSTRICTION: A RARE CASE OF CARDIAC ANGIOSARCOMA	52
ISCHEMIA INDUCED BY A GIANT RIGHT CORONARY ARTERY ANEURYSM	52
Audio Summary	52
IS SACUBITRIL/VALSARTAN LESS LIKELY TO BE PRESCRIBED IN ELDERLY PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION? A ROOT CAUSE ANALYSIS	52
ASSOCIATION OF AGE WITH ORAL ANTICOAGULANT PRESCRIPTION AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION: INSIGHTS FROM A UNITED STATES COMMERCIAL CLAIMS DATABASE	52
CARDIAC AMYLOIDOSIS- A WOLF IN SHEEP'S SKIN	52